Literature DB >> 29202217

DNA Modulates the Interaction of Genetically Engineered DNA-Binding Proteins and Gold Nanoparticles: Diagnosis of High-Risk HPV Infection.

Ju-Yi Mao1, Han-Wei Li2, Shih-Chun Wei, Scott G Harroun3, Ming-Ying Lee, Hung-Yun Lin, Chih-Yu Chung4, Chun-Hua Hsu, Yet-Ran Chen, Han-Jia Lin, Chih-Ching Huang5.   

Abstract

Gene detection has an important role in diagnosing several serious diseases and genetic defects in modern clinical medicine. Herein, we report a fast and convenient gene detection method based on the modulation of the interaction between a heat-resistant double-stranded DNA (dsDNA)-binding protein (Sso7d) and gold nanoparticles (Au NPs). We prepared a recombinant Cys-Sso7d, which is Sso7d with an extra cysteine (Cys) residue in the N-terminus, through protein engineering to control the interaction between Sso7d and Au NPs. Cys-Sso7d exhibited a stronger affinity for Au NPs and more easily induced the aggregation of Au NPs than Sso7d. In addition, Cys-Sso7d retained its ability to bind with dsDNA. The aggregation of Au NPs induced by Cys-Sso7d was diminished in the presence of dsDNA, which could be utilized as a transduction mechanism for the detection of the polymerase chain reaction (PCR) products of human papillomavirus (HPV) gene fragments (HPV types 16 and 18). The Cys-Sso7d/Au NP probe could detect as few as 1 copy of the HPV gene. The sensitivity and specificity of the Cys-Sso7d/Au NP probe for Pap smear clinical specimens (n = 52) for HPV 16 and HPV 18 detection were 85.7%/100.0% and 85.7%/91.7%, respectively. Our results demonstrate that the Cys-Sso7d/Au NP probe can be used to diagnose high-risk HPV types in Pap smear samples with high sensitivity, specificity, and accuracy.

Entities:  

Keywords:  DNA-binding proteins; clinical diagnosis; gene detection; genetic engineering; gold nanoparticles; human papillomavirus

Mesh:

Substances:

Year:  2017        PMID: 29202217     DOI: 10.1021/acsami.7b13873

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  2 in total

1.  Development of label-free gold nanoparticle based rapid colorimetric assay for clinical/point-of-care screening of cervical cancer.

Authors:  Tejaswini Appidi; Sushma V Mudigunda; Suseela Kodandapani; Aravind Kumar Rengan
Journal:  Nanoscale Adv       Date:  2020-10-07

2.  Electrochemical detection of NGF using a reduced graphene oxide- titanium nitride nanocomposite.

Authors:  Zheng Wei; Yanchun Wang; Junping Zhang
Journal:  Sci Rep       Date:  2018-05-02       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.